Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma (Q35023451)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma |
scientific article |
Statements
1 reference
Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma (English)
1 reference
Bert H O'Neil
1 reference
Laura W Goff
1 reference
John Sae Wook Kauh
1 reference
Jonathan R Strosberg
1 reference
Tanios S Bekaii-Saab
1 reference
Ruey-Min Lee
1 reference
Aslamuzzaman Kazi
1 reference
Dominic T Moore
1 reference
Maria Learoyd
1 reference
Richard M Lush
1 reference
Said M Sebti
1 reference
Daniel M Sullivan
1 reference
25 April 2011
1 reference
1 reference
1 reference
Identifiers
1 reference